Atlas Trials

A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)

Clinical trial NCT05378529 · COMPLETED

Trial details

NCT number
NCT05378529
Sponsor
Amgen
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2022-04-19
Primary completion
2023-12-30
Enrollment
39480

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.